Metformin use linked to lower odds of new-onset neovascular age-related macular degeneration

Metformin use is associated with reduced odds of new-onset International Classification of Diseases (ICD) coding of neovascular age-related macular degeneration (nAMD), according to a study published online Jan. 30 in Ophthalmology Retina.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup